Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Virtual reality headset aims to restore lost vision

NCT ID NCT07185971

First seen Sep 30, 2025 · Last updated May 22, 2026 · Updated 40 times

Summary

This study tests a virtual reality system called PAVE to help people with long-term vision loss from stroke, brain injury, or brain surgery. Participants use a VR headset three times a week for eight weeks to stimulate their visual field. The goal is to see if this therapy can expand their field of view and improve daily visual function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HOMONYMOUS HEMIANOPSIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dr. D. M. Fitzgerald & Associates

    RECRUITING

    Cedar Rapids, Iowa, 52404, United States

    Contact

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Neuro-Vision Associates of North Texas

    RECRUITING

    Prospect, Kentucky, 40059, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.